Login / Signup

Immune checkpoint inhibitor combination therapy leads to more nephrotoxicity in advanced renal cell carcinoma patients.

Yu-Xuan SongSongchen HanTao Xu
Published in: World journal of urology (2023)
Keyphrases
  • combination therapy
  • end stage renal disease
  • renal cell carcinoma
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • patient reported